| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Prinzing Eyewash Station | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | 6368bb69-43e9-4304-a30d-03d593c1c05f | 4 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CP2D/AS-3 Blood Collection and Sampling System | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CP2D/AS-3 Blood Collection and Sampling System | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CP2D/AS-3 Blood Collection and Sampling System | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | These highlights do not include all the information needed to use PROCRIT safely and effectively. See full prescribing information for PROCRIT. PROCRIT ® (epoetin alfa) injection, for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | PHOSPHA 250™ NEUTRAL Supplies 250 mg of phosphorus per tablet | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | I-123 MIBG | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | Unknown Title | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CP2D/AS-3 Blood Collection and Sampling System | 3 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | dc35ba25-8746-4ed8-83c1-e6b6a1057863 | 5 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Sperian Eyesaline Eyewash | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Alclometasone Dipropionate Cream USP, 0.05% Alclometasone Dipropionate Ointment USP, 0.05% | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | 82b2fffd-4a1f-4ea3-b156-b8dc51bfde52 | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Clotrimazole Drug Facts | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | Sterile Cord Blood Collection Unit Code 791-08 | 3 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Nasal Decongestant Drug Facts | 2 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Betamethasone Valerate Cream USP, 0.1% | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Buffered Eye-Lert | 12 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | 983ce15f-cd37-4f3a-9e51-205860e80976 | 3 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | Calcitriol Injection Rx Only | 3 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DRUG FACTS | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | MOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%) | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ARANESP (DARBEPOETIN ALFA) INJECTION, SOLUTION ARANESP (DARBEPOETIN ALFA) SOLUTION [AMGEN INC] | 138 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | EPOGEN (EPOETIN ALFA) SOLUTION [AMGEN INC] | 121 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ROTATEQ (ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT) SOLUTION [MERCK SHARP & DOHME CORP.] | 27 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | TYSABRI (NATALIZUMAB) INJECTION [ELAN PHARMACEUTICALS, INC.] | 26 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | TYSABRI (NATALIZUMAB) INJECTION [BIOGEN IDEC INC.
] | 22 | |
| Sodium Phosphate, Monobasic, Monohydrate | INACTIVE INGREDIENT | 593YOG76RN | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | PROCRIT (ERYTHROPOIETIN) INJECTION, SOLUTION [JANSSEN PRODUCTS, LP] | 21 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | OSMOPREP (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC.] | 20 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | SOMAVERT (PEGVISOMANT) KIT [PHARMACIA AND UPJOHN COMPANY] | 18 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | DEFINITY (PERFLUTREN) INJECTION, SUSPENSION [LANTHEUS MEDICAL IMAGING, INC.] | 17 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | FABRAZYME (AGALSIDASE BETA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION] | 17 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | DOXERCALCIFEROL INJECTION, SOLUTION [SANDOZ INC] | 15 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.] | 15 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ORENCIA (ABATACEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ORENCIA (ABATACEPT) INJECTION, SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | 15 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ZALTRAP (ZIV-AFLIBERCEPT) SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC] | 14 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 13 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | LOTRISONE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE) CREAM [MERCK SHARP & DOHME CORP.] | 13 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | MD-76R (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) SOLUTION [MALLINCKRODT INC.] | 13 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE) SUSPENSION [CHATTEM, INC.] | 12 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | BYDUREON (EXENATIDE) INJECTION, SUSPENSION, EXTENDED RELEASE BYDUREON (EXENATIDE) KIT [ASTRAZENECA PHARMACEUTICALS LP] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | IONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | IONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ISTALOL (TIMOLOL MALEATE) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED] | 11 | |
| Sodium Phosphate, Monobasic, Monohydrate | INACTIVE INGREDIENT | 593YOG76RN | MENVEO (MENINGOCOCCAL (GROUPS A, C, Y AND W-135) OLIGOSACCHARIDE DIPHTHERIA CRM197 CONJUGATE VACCINE) KIT [NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | MYOZYME (ALGLUCOSIDASE ALFA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | SODIUM PHOSPHATES (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | AMPHOTERICIN B INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.] | 10 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ELOCON (MOMETASONE FUROATE) LOTION [MERCK SHARP & DOHME CORP.] | 10 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | NAGLAZYME (GALSULFASE) SOLUTION [BIOMARIN PHARMACEUTICAL INC.] | 10 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 9 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 9 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ALCLOMETASONE DIPROPIONATE CREAM ALCLOMETASONE DIPROPIONATE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 8 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | DIPROLENE (BETAMETHASONE DIPROPIONATE) LOTION [MERCK SHARP & DOHME CORP.] | 8 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | LUMIZYME (ALGLUCOSIDASE ALFA) INJECTION, POWDER, FOR SOLUTION [GENZYME CORPORATION] | 8 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | STRENSIQ (ASFOTASE ALFA) SOLUTION [ALEXION PHARMACEUTICALS INC.] | 8 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | VIMIZIM (ELOSULFASE ALFA) INJECTION, SOLUTION, CONCENTRATE [BIOMARIN PHARMACEUTICAL INC.] | 8 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJECTION, SUSPENSION [AMERICAN REGENT, INC.] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION) SOLUTION [FENWAL, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | GONAL-F RFF (FOLLITROPIN ALFA) KIT [EMD SERONO, INC.] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | HECTOROL (DOXERCALCIFEROL) INJECTION, SOLUTION [GENZYME CORPORATION] | 7 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | IFOSFAMIDE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) BLOOD-PACK UNITS IN PL 146 PLASTIC (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION) SOLUTION [FENWAL, INC.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) BLOOD-PACK UNITS IN PL 146 PLASTIC (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)) SOLUTION [FENWAL, INC.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CPD (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)) SOLUTION [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | INTERSOL (PLATELET ADDITIVE 3) SOLUTION [FENWAL, INC.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ISOSULFAN BLUE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | MANZANILLA SOPHIA (CHAMOMILE (MATRICARIA CHAMOMILLA L.)) SOLUTION/ DROPS [LABORATORIOS SOPHIA, S.A. DE C.V.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | MTL1 LEUCOFLEX (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION WITH AS-1) KIT [MACO PRODUCTIONS] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | NEUMEGA (OPRELVEKIN) KIT [WYETH BIOPHARMA DIVISION OF WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | VISICOL (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC] | 6 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CALCITRIOL INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE LOTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | COUMADIN (WARFARIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, LTD. LIABILITY COMPANY] | 5 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ACTIVE INGREDIENT | 593YOG76RN | CPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 5 | |